AIBORN Gets Investment From Medical Data Vision, Forms Alliance
The investment formalizes a sales arrangement that has been running since August 2025 and gives the Katanashi product a partner with one of Japan's largest clinical databases behind its distribution to medical institutions.
Reporting from 1 source: ASCII.jp.
AIBORN Inc. announced it has received an investment from Medical Data Vision Co., Ltd. and formed a capital and business alliance. MDV has acted as a sales agent for AIBORN's medical record AI tool Katanashi since August 2025. The two companies will work together on product development, provision to medical institutions, and post-implementation support to reduce documentation work for healthcare professionals.
MDV has acted as a sales agent for Katanashi since August 2025, promoting the tool to medical institutions. Katanashi transcribes consultation and conference conversations and uses AI to summarize them in formats such as SOAP, supporting record drafting for physicians, nurses, and other professionals.
AIBORN developed the product to cut the time clinicians spend on input work. Under the alliance, the two companies will collaborate on product development, provision to medical institutions, and support after implementation, with field feedback fed back into product improvements.
Synthesized by Yomimono from the 1 cited source below, including Japanese-language reporting where cited, then editorially reviewed before publishing.
Sources
- ASCII.jp AIBORN、メディカル・データ・ビジョンからの出資を受け資本業務提携